Khiron Raising $20 Million Selling Shares at $2.20

Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing VANCOUVER, Feb. 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF),...
- February 6th, 2019 at 8:16 am

Khiron to Raise Capital

Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) — Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN,...
- August 21st, 2018 at 4:36 pm

Khiron CBD Products Gain Colombian Regulatory Approval

Khiron Receives INVIMA Approval to Commercialize CBD Products for Colombian Domestic Sale and Export First Fully Licensed Company in Colombia to Receive INVIMA Approval TORONTO, May 30, 2018 /CNW/ – Khiron life Sciences...
- May 30th, 2018 at 8:27 am